The total return over the past 12 months is +36.48% vs. +17.49% for the S&P 500. So far it's up +23.29% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +35.57% | +0.23% | (11.00%) | +10.51% | +9.92% | +9.24% |
| Total Return CAGR | +36.48% | +0.79% | (10.58%) | +11.18% | +10.90% | +10.25% |
| Revenue CAGR | (0.38%) | +2.25% | +5.47% | +9.31% | +10.02% | +9.37% |
| Net Income CAGR | +147.77% | (13.93%) | +5.31% | +5.70% | +3.27% | +4.64% |
| EPS CAGR | +154.35% | +4.57% | +5.16% | +5.27% | +2.92% | +4.67% |
| Free Cash Flow CAGR | +2.60% | +6.79% | (3.08%) | +7.56% | +5.17% | +6.07% |
| Operating Cash Flow CAGR | +1.57% | +4.71% | (3.67%) | +7.34% | +5.70% | +6.33% |
| Dividends CAGR | 0.00% | 0.00% | 0.00% | 0.00% | +1.08% | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bio-Techne Corporation (TECH)
| Year | Start price | End price | TECH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $58.81 | $72.12 | +23.29% | +11.72% | +11.57% |
| 2025 | $72.03 | $58.81 | (17.89%) | +17.72% | (35.61%) |
| 2024 | $77.16 | $72.03 | (6.25%) | +24.89% | (31.14%) |
| 2023 | $82.88 | $77.16 | (6.49%) | +26.19% | (32.68%) |
| 2022 | $129.34 | $82.88 | (35.70%) | (18.17%) | (17.53%) |
| 2021 | $79.39 | $129.34 | +63.39% | +28.74% | +34.65% |
| 2020 | $54.88 | $79.39 | +45.39% | +18.37% | +27.02% |
| 2019 | $36.18 | $54.88 | +52.68% | +31.22% | +21.46% |
| 2018 | $32.39 | $36.18 | +12.60% | (4.56%) | +17.16% |
| 2017 | $25.71 | $32.39 | +27.40% | +21.70% | +5.70% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
